CPT1B
Basic information
Region (hg38): 22:50568861-50578465
Links
Phenotypes
GenCC
Source:
- inherited fatty acid metabolism disorder (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPT1B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 59 | 62 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 1 | |||||
Total | 0 | 0 | 61 | 4 | 3 |
Variants in CPT1B
This is a list of pathogenic ClinVar variants found in the CPT1B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-50569342-C-G | not specified | Uncertain significance (May 28, 2024) | ||
22-50569343-T-G | not specified | Uncertain significance (Dec 09, 2023) | ||
22-50569347-G-C | Benign (Aug 16, 2018) | |||
22-50569348-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
22-50569369-T-C | not specified | Uncertain significance (Dec 07, 2021) | ||
22-50569412-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
22-50569577-G-A | not specified | Uncertain significance (May 05, 2023) | ||
22-50570351-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
22-50570363-TG-T | CPT1B-related disorder | Uncertain significance (Mar 09, 2023) | ||
22-50570371-C-G | not specified | Uncertain significance (Feb 01, 2023) | ||
22-50570881-C-T | CPT1B-related disorder | Likely benign (Sep 08, 2022) | ||
22-50570910-C-T | not specified | Uncertain significance (May 20, 2024) | ||
22-50570914-C-G | not specified | Uncertain significance (Nov 17, 2022) | ||
22-50570971-C-T | not specified | Uncertain significance (Mar 31, 2022) | ||
22-50570977-T-C | not specified | Uncertain significance (Jan 04, 2024) | ||
22-50570985-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
22-50571058-T-C | not specified | Benign (-) | ||
22-50571165-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
22-50571172-C-T | not specified | Uncertain significance (Sep 20, 2022) | ||
22-50571216-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
22-50571240-C-G | not specified | Uncertain significance (Nov 22, 2021) | ||
22-50571288-C-T | not specified | Likely benign (Apr 13, 2023) | ||
22-50571432-C-A | not specified | Uncertain significance (May 16, 2022) | ||
22-50571443-G-C | not specified | Uncertain significance (Dec 03, 2021) | ||
22-50571473-A-C | not specified | Uncertain significance (Feb 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CPT1B | protein_coding | protein_coding | ENST00000360719 | 18 | 10610 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.53e-11 | 0.986 | 125637 | 1 | 107 | 125745 | 0.000430 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.494 | 449 | 479 | 0.936 | 0.0000301 | 5077 |
Missense in Polyphen | 106 | 120.19 | 0.88191 | 1210 | ||
Synonymous | 0.251 | 181 | 185 | 0.977 | 0.0000116 | 1493 |
Loss of Function | 2.44 | 24 | 40.8 | 0.588 | 0.00000190 | 459 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000796 | 0.000796 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000656 | 0.000653 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000441 | 0.000431 |
Middle Eastern | 0.000656 | 0.000653 |
South Asian | 0.000692 | 0.000653 |
Other | 0.000494 | 0.000489 |
dbNSFP
Source:
- Pathway
- Adipocytokine signaling pathway - Homo sapiens (human);Insulin resistance - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);AMP-activated Protein Kinase (AMPK) Signaling;Fatty Acid Beta Oxidation;PPAR signaling pathway;Signal Transduction;mitochondrial L-carnitine shuttle;Metabolism of lipids;Import of palmitoyl-CoA into the mitochondrial matrix;Metabolism;Fatty acid metabolism;Signaling by Retinoic Acid;Signaling by Nuclear Receptors;FOXA2 and FOXA3 transcription factor networks
(Consensus)
Recessive Scores
- pRec
- 0.348
Intolerance Scores
- loftool
- 0.0174
- rvis_EVS
- -0.66
- rvis_percentile_EVS
- 16.02
Haploinsufficiency Scores
- pHI
- 0.112
- hipred
- N
- hipred_score
- 0.229
- ghis
- 0.436
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Cpt1b
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- fatty acid beta-oxidation;carnitine shuttle;carnitine metabolic process;long-chain fatty acid transport
- Cellular component
- mitochondrion;mitochondrial outer membrane;integral component of membrane
- Molecular function
- carnitine O-palmitoyltransferase activity;protein binding